Physician profile
Stephen Burke Gunther
NPI 1285613034
$544,955.78
in general payments reported to CMS, 2019-2025
3 companies · $225K in 2025
The $225K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $14K · 2021: $15K · 2022: $34K · 2023: $66K · 2024: $181K · 2025: $225K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $402K · Consulting Fee: $57K · Travel and Lodging: $10K · Food and Beverage: $1,450 · Gift: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $402,051.83 |
| Consulting Fee | $56,974.00 |
| Travel and Lodging | $10,172.94 |
| Food and Beverage | $1,450.25 |
| Gift | $521.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $544,828.49 | 2019-2025 | Inset System |
| Smith+Nephew, INC. | $98.36 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $28.93 | 2025 | Dynacord, Healix Knotless Peek, Truespan Orthocord |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,359,842.85 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Gunther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.